10 likes | 171 Views
Figure 4 Pathological assessment of immune effector cells associated with melanoma brain metastases following ipilimumab treatment. Hodi FS et al . (2008) CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
E N D
Figure 4 Pathological assessment of immune effector cells associated with melanoma brain metastases following ipilimumab treatment Hodi FS et al. (2008) CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS Nat Clin Pract Oncol doi:10.1038/ncponc1183